echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Amino Acids Research > DeGusay to establish Lysine joint venture in Russia

    DeGusay to establish Lysine joint venture in Russia

    • Last Update: 2020-07-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Evonik Industries of Germany has set up a joint venture with RusBiotech International and plans to build a plant for animal feeding in RussiaThe plant is scheduled to be built in Volgodonsk in 2014 at a cost of about $200 millionEvonik, based in Essen, Germany, has invested less in joint ventures, but said they would increase its shareThe project has the support of Rostov's regional managers and will build the plant thereEvonik and RusBiotech, who are also in talks about a possible takeover of A- Rusnano, Russia's state-owned nanotechnology company, in the joint ventureRusnano, Russia's state-owned nanotechnology company, has been increasing its partnership with Western companies, recently investing in a joint venture with The Us company Cleveland BioLabs and Pro Bono Bio in the UNITED Kingdom's recent win-creation of a joint venture with lysine reflects their intention to increase the market share of amino acidsNotably, the company recently announced a project to increase the capacity of the Lysine plant in B.A., Nebraska, and a $500 million project to build a new methionine plant in SingaporeEvonik Industries of Germany and RusBiotech International have set up a joint venture and plan to build a plant for animal feeding in RussiaThe plant is scheduled to be built in Volgodonsk in 2014 at a cost of about $200 millionEvonik, based in Essen, Germany, has invested less in joint ventures, but said they would increase its shareThe project has the support of Rostov's regional managers and will build the plant thereEvonik and RusBiotech, who are also in talks about a possible takeover of A- Rusnano, Russia's state-owned nanotechnology company, in the joint ventureRusnano, Russia's state-owned nanotechnology company, has been increasing its partnership with Western companies, recently investing in a joint venture with The Us company Cleveland BioLabs and Pro Bono Bio in the UNITED Kingdom's recent win-creation of a joint venture with lysine reflects their intention to increase the market share of amino acidsNotably, the company recently announced a project to increase the capacity of the Lysine plant in B.A., Nebraska, and a $500 million project to build a new methionine plant in Singapore(
    name) 
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.